Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Fund Levin Capital Strategies’ Stock Picks for 2013

JPMorgan Chase & Co. (NYSE:JPM), which was one of the most popular stocks among hedge funds in the third quarter of 2012 (see the full top ten list), was another of Levin’s favorite stocks in Q4. The fund entered 2013 with 4.6 million shares of the megabank in its portfolio. We like the combination of value and stability that JPMorgan Chase offers: even with its decent reputation compared to banks such as Bank of America Corp (NYSE:BAC) and Citigroup Inc. (NYSE:C) it still trades at a small discount to the book value of its equity and at 9 times forward earnings estimates; that forward P/E is in line with how those peers are valued.

Levin upped its stake in Medtronic, Inc. (NYSE:MDT) from about 3 million shares at the beginning of October to 4.4 million shares at the end of December. In Medtronic’s most recent quarterly report, for the quarter ending in October, net income was down 26% from a year earlier and revenue growth, while positive, was only modest. While the earnings multiples are low for a large-cap company- the trailing P/E is 14, for example- we don’t like the company’s recent performance and would avoid it for now. Diamond Hill Capital, managed by Ric Dillon, is another major Medtronic shareholder (research more stocks Diamond Hill owns).

Macy’s, Inc. (NYSE:M) rounded out Levin’s five largest 13F holdings. The department store has actually been reporting decent numbers recently, and is a candidate for value status with trailing and forward P/Es of 12 and 11 respectively. Analyst expectations imply a five-year PEG ratio of 0.9. We don’t particularly like the industry but the value metrics look good and the company’s performance appears acceptable. Lee Ainslie’s Maverick Capital initiated a position of 5.7 million shares in Macy’s during Q3 2012 (find more stocks Ainslie was buying).

Disclosure: I own no shares of any stocks mentioned in this article.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!